比伐卢定
医学
肝素
重症监护医学
心脏病学
内科学
经皮冠状动脉介入治疗
心肌梗塞
作者
Saurabh Gupta,Joaquin E. Cigarroa
摘要
Key Points Bleeding rates with unfractionated heparin (UH) without concomitant use of glycoprotein IIb/IIIa inhibitors as compared to bivalirudin are similar. Ischemic event rates during the index hospitalization are similar in the heparin and bivalirudin subgroups. Low does heparin (60–70 units/kg) with a target ACT of 200–250 sec may obviate the historical improved safety of bivalirudin demonstrated in certain clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI